Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.

The ALS Network is supporting research using electronic health records to identify existing drugs for repurposing to slow ALS ...

ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...

Patients with less neuronal damage, determined by low spinal fluid pNFH, had a 48% reduction in the risk of death by adding ...

Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

What does coping mean in life? Columnist Kristin Neva mulls it over after she and her husband with ALS take a mental health survey.

The FDA has cleared Brainstorm to initiate a Phase 3b clinical trial testing NurOwn (debamestrocel) in people with moderate ALS.

Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...

ALS Awareness Month amplifies difficult emotions for columnist. It's one of the reasons why sharing is important.

Clene will soon meet with the Food and Drug Administration to discuss analyses that could support an application for ...

Columnist Kristin Neva, inspired by a Bon Iver song, investigates old journals as she thinks about the rhythm of her life.